Heterozygous de-Novo Mutations in ATP1A3 in Patients with Alternating Hemiplegia of Childhood:A Whole-Exome Sequencing Gene-Identification Study
Lancet Neurol 11:764-773, Rosewich,H.,et al, 2012
Post-acute care and secondary prevention after ischaemic stroke
BMJ 342:d2083, McArthur, K.S.,et al, 2011
Assessment of Aspiration Risk in Stroke Patients with Quantification of Voluntary Cough
Neurol 56:502-506, Hammond,C.A.S.,et al, 2001
Epidemiology, Survival, and Clinical Characteristics of Inclusion Body Myositis
Ann Neurol 92:201-212, Lindgren, U.,et al, 2022
Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
Advanced Dementia
NEJM 372:2533-2540, Mitchell, S.L., 2015
Mystery Case: A 63-year-old Man with Progressive Proximal Pain and Weakness
Neurol 82:e26-e29, Scripko, P.D.,et al, 2014
A 32-year-old Woman with Right-Sided Numbness and Word-Finding Difficulties
Neurol 83:e98-e102, Busza, A.,et al, 2014
Late onset autism and anti-NMDA-receptor encephalitis
Lancet 378:98;378, Creten, C.,et al, 2011
Transverse Myelitis
NEJM 363:564-572, Frohman,E.M. &Wingerchuk,D.M., 2010
Neurological Consequences of Atrioesophageal Fistula After Radiofrequency Ablation in Atrial Fibrillation
Arch Neurol 66:884-887, St�llberger,C.,et al, 2009
Investigating the Hoarse Voice
BMJ 337:1165-1168, Pretorius,P.M. &Milford,C.A., 2008
Amyotrophic Lateral Sclerosis
Lancet 369:2031-2041, Mitchell,J.D. & Borasio,G.D., 2007
Severe Botulism After Focal Injection of Botulinum Toxin
Neurol 67:1855-1856, Souayah,N.,et al, 2006
Botulism in 4 Adults Following Cosmetic Injections With an Unlicensed, Highly Concentrated Botulinum Preparation
JAMA 296:2476-2479,2512, Chertow,D.S.,et al, 2006
Dysphagia After Stroke
Stroke 36:2756-2763, Martino,R.,et al, 2005
Oculopharyngeal Muscular Dystrophy in Hispanic New Mexicans
JAMA 286:2437-2440, Becher,M.W.,et al, 2001
Safety and Factors Related to Survival After Percutaneous Endoscopic Gastrostomy in ALS
Neurol 53:1123-1125, Chio,A.,et al, 1999
X Linked Adrenoleukodystrophy:Clinical Presentation, Diagnosis, and Therapy
JNNP 63:4-14, vanGeel,B.M.,et al, 1997
Explaining Oropharyngeal Dysphagia After Unilateral Hemispheric Stroke
Lancet 350:686-692, Hamdy,S.,et al, 1997
Complications and Outcome After Acute Stroke:Does Dysphagia Matter
Stroke 27:1200-1204, Smithard,D.G.,et al, 1996
Dysphagia Therapy Following Stroke:A Controlled Trial
Neurol 44:1655-1660, DePippo,K.L.,et al, 1994
Motor Neuron Disease
JNNP 57:886-896, Leigh,P.N.&Ray-Chaudhuri,K., 1994
Complications of Acute Stroke
Lancet 339:721-724, Oppenheimer,S.&Hachinski,V., 1992
Dysphagia After Botulinum Toxin Injections for Spasmodic Torticolli:Clinical and Radiologic Findings
Neurol 42:1307-1310, Comella,C.L.,et al, 1992
Tardive Dyskinesia Presenting as Severe Dysphagia
JNNP 55:1203-1204, Gregory,R.P.,et al, 1992
Botulinum Toxin Treatment of Tremors
Neurol 41:1185-1188, Jankovic,J.&Schwartz,K., 1991
Clinical Use of Botulinum Toxin
National Institutes of Health Consensus Develop Conf Stmt, Nov 12-14, 1990, Arch Neurol 48:1294-1298, 199, 1991
Clinical Correlates of Response to Botulinum Toxin Injections
Arch Neurol 48:1253-1256, Jankovic,J.&Schwartz,K.S., 1991
Botulinum Toxin Injections for Cervical Dystonia
Neurol 40:277-280, Jankovic,J.&Schwartz,P.A., 1990
Botulinum Toxin Treatment in Spasmodic Torticollis
JNNP 53:640-643, Blacke,J.D.&Lees,A.J., 1990
Clinical Features and Associations of 560 Cases of Motor Neuron Disease
JNNP 53:1043-1045, Li,T.,et al, 1990
Neurological Deficit After Carotid Endarterectomy
Am J Nursing 79:654-658, Webb,P.H., 1979
Neurologic Manifestations of Progressive Systemic Sclerosis, 1972
Nebraska Med J 58:106, Aita,J.A., 1973